Phathom Pharmaceuticals, Inc. (PHAT)
NMS – Real Time Price. Currency in USD
8.60
+0.09 (1.06%)
Market open: Aug 12, 2026, 11:13 AM EDT
8.46
-0.05 (-0.58%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
8.60
+0.09 (1.06%)
Market open: Aug 12, 2026, 11:13 AM EDT
8.46
-0.05 (-0.58%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Total debt $552.0M significantly exceeds cash reserves ($182.5M), raising financial stability concerns
Total current assets $295.9M exceed Total current liabilities $153.8M, highlighting excellent liquidity
Debt-to-equity ratio (-1.6) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-0.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$2.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.92 | 6.05 | 9.0 | |
| Quick ratio | 1.87 | 5.63 | 9.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 1.69 | 1.04 | 1.0 | |
| Interest coverage | -0.26 | -16.91 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 682K | 55M | 175M | 240M |
| Gross Profit | -620K | -60K | 47M | 153M | 199M |
| Operating Income | -172M | -167M | -277M | -160M | -41M |
| Net Income | -198M | -202M | -334M | -221M | -99M |
| EBITDA | -172M | -167M | -277M | -159M | -40M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 72.56 | 85.07 | 10 |
| Next quarter | 71.15 | 104.41 | 10 |
| Current year | 80.78 | 74.48 | 10 |
| Next year | 56.16 | 219.44 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 27.4 | 42.11 | 43.24 | 87.43 | 10 |
| Y/Y | 88.02 | 76.81 | 80 | 96.86 | 10 |
| 3y average | 3072.47 | -11.31 | 10.1 | -16.2 | 4.8 |
| 5y average | 2243.08 | -16.56 | 0.05 | -31.65 | 3.5 |
| Weighted average score | 7.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |